ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus

June 6, 2014

In Brief: DTP Combines Two Branches; Robert Cooper Names DCPC Board Chairman Weicker Receives MSK Award

June 28, 1985

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

NIGMS Forms Bioinformatics, Computational Bio Center.

May 25, 2001

In Brief: Hedlund To Head Prostate Cancer Coalition; USCF Forms Human Genetics Program

July 25, 1997

Cell Culture ID Offered By NIC

January 7, 1983